- ENTA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Enanta Pharmaceuticals (ENTA) 10-K/A2016 FY Annual report (amended)
Filed: 6 Jan 17, 12:00am
Exhibit 31.2
Certification Pursuant toSection 240.13a-14 or240.15d-14
of the Securities Exchange Act of 1934, as amended
I, Paul J. Mellett, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form10-K of Enanta Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: January 6, 2017
/s/ Paul J. Mellett |
Paul J. Mellett |
Chief Financial Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.